Literature DB >> 17461462

Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature.

Ning Dai1, Ying-Cong Yu, Tian-Hua Ren, Jia-Guo Wu, Yuan Jiang, Lai-Gen Shen, Jing Zhang.   

Abstract

Gynura root has been used extensively in Chinese folk medicine and plays a role in promoting microcirculation and relieving pain. However, its hepatic toxicity should not be neglected. Recently, we admitted a 62-year old female who developed hepatic veno-occlusive disease (HVOD) after ingestion of Gynura root. Only a few articles on HVOD induced by Gynura root have been reported in the literature. It is suspected that pyrrolizidine alkaloids in Gynura root might be responsible for HVOD. In this paper, we report a case of HVOD and review the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17461462      PMCID: PMC4146912          DOI: 10.3748/wjg.v13.i10.1628

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  [Studies on the alkaloids of Gynura segetum (Lour.) Merr].

Authors:  S Q Yuan; G M Gu; T T Wei
Journal:  Yao Xue Xue Bao       Date:  1990

2.  Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.

Authors:  X Wang; G C Kanel; L D DeLeve
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

Review 3.  Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids.

Authors:  Mario Chojkier
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

4.  Serous hepatosis: a pathogenesis of hepatic fibrosis in Jamaican children.

Authors:  K R HILL; K RHODES; J L STAFFORD; R AUB
Journal:  Br Med J       Date:  1953-01-17

Review 5.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

6.  [Hepatic veno-occlusive disease: report of two cases].

Authors:  Wei-xing Chen; Ming Yang; Chao-hui Yu; You-ming Li
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2005-05

7.  TIPS for veno-occlusive disease: is the contraindication real?

Authors:  Marco Senzolo; Evangelos Cholongitas; David Patch; Andrew Kenneth Burroughs
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

8.  A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation.

Authors:  Il-Deok Kim; Hiroto Egawa; Yuhji Marui; Satoshi Kaihara; Hironori Haga; Ying-Wei Lin; Kazuko Kudoh; Tetsuya Kiuchi; Shinji Uemoto; Koichi Tanaka
Journal:  Am J Transplant       Date:  2002-09       Impact factor: 8.086

9.  Long- and short-term D-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression.

Authors:  M Chojkier; K Houglum; K S Lee; M Buck
Journal:  Am J Physiol       Date:  1998-12

10.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

View more
  13 in total

1.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

2.  Herbal tea-induced hepatic veno-occlusive disease in China: a case description.

Authors:  Bo Li; Fabao Gao; Xinai Liu; Junzheng Pan; Lin Liu
Journal:  Quant Imaging Med Surg       Date:  2021-08

3.  Monitoring of pyrrolizidine alkaloids in beehive products and derivatives on the Belgian market.

Authors:  Jean-François Picron; Mélanie Herman; Els Van Hoeck; Séverine Goscinny
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-18       Impact factor: 4.223

Review 4.  Use of herbal products and potential interactions in patients with cardiovascular diseases.

Authors:  Ara Tachjian; Viqar Maria; Arshad Jahangir
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

5.  Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.

Authors:  Fang Zhang; Yue Zhou; Xiao Yang; Ai-Zhen Xiong; Zheng-Tao Wang; Li Yang
Journal:  Acta Pharmacol Sin       Date:  2018-10-26       Impact factor: 6.150

6.  Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid.

Authors:  Aizhen Xiong; Fan Yang; Lianxiang Fang; Li Yang; Yuqi He; Yu-Jui Yvonne Wan; Yvonne Yu-Jui Wan; Ying Xu; Meng Qi; Xiuli Wang; Kate Yu; Karl Wah-Keung Tsim; Zhengtao Wang
Journal:  Chem Res Toxicol       Date:  2014-04-01       Impact factor: 3.739

Review 7.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

8.  Hepatic veno-occlusive disease related to Gynura segetum: A case report.

Authors:  Ziyi Sun; Jianmei Kang; Yongchang Zhang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 9.  Pyrrolizidine Alkaloids: Biosynthesis, Biological Activities and Occurrence in Crop Plants.

Authors:  Sebastian Schramm; Nikolai Köhler; Wilfried Rozhon
Journal:  Molecules       Date:  2019-01-30       Impact factor: 4.411

Review 10.  Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review.

Authors:  Tong-Yin Zhu; Guan-Hui Zhou; Xin-Hua Chen; Xiao-Dong Teng; Jun-Hui Sun
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.